Peter W Schiller Selected Research

2',6'- dimethyltyrosyl- arginyl- phenylalanyl- lysinamide

11/2015	The bifunctional μ opioid agonist/antioxidant [Dmt(1)]DALDA is a superior analgesic in an animal model of complex regional pain syndrome-type i.
11/2012	Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain.
2/2012	Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
1/2009	Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
3/2005	Differential respiratory effects of [Dmt1]DALDA and morphine in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter W Schiller Research Topics

Disease

9	Tics (Tic) 03/2015 - 05/2005
8	Neuralgia (Stump Neuralgia) 01/2018 - 11/2012
5	Pain (Aches) 01/2019 - 04/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 11/2011
2	Acute Pain 10/2017 - 01/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2016 - 03/2005
2	Hyperalgesia 11/2015 - 11/2012
2	Cocaine-Related Disorders (Cocaine Addiction) 04/2014 - 09/2013
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Hypersensitivity (Allergy) 10/2017
1	Chronic Pain 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 11/2015
1	Ischemia 11/2015
1	Obesity 10/2014
1	Weight Gain 10/2014
1	Cardiomyopathies (Cardiomyopathy) 10/2011
1	Heart Diseases (Heart Disease) 10/2011
1	Sepsis (Septicemia) 03/2010
1	Hypoxia (Hypoxemia) 03/2005
1	Myocardial Stunning (Stunned Myocardium) 08/2004
1	Reperfusion Injury 08/2004

Drug/Important Bio-Agent (IBA)

10	Opioid Analgesics (Opioids)IBA 10/2017 - 01/2009
10	Analgesics (Analgesic Drugs)IBA 10/2017 - 04/2008
9	Peptides (Polypeptides)IBA 01/2019 - 08/2004
7	Morphine (MS Contin)FDA LinkGeneric 01/2016 - 03/2005
6	Carboxylic AcidsIBA 09/2013 - 10/2005
5	2',6'- dimethyltyrosyl- arginyl- phenylalanyl- lysinamideIBA 11/2015 - 03/2005
5	1,2,3,4-tetrahydroisoquinolineIBA 09/2013 - 10/2005
5	Opioid Peptides (Opioid Peptide)IBA 11/2012 - 03/2005
4	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 09/2013 - 01/2007
3	Pharmaceutical PreparationsIBA 01/2018 - 04/2014
3	LigandsIBA 01/2016 - 04/2011
3	AntioxidantsIBA 01/2016 - 08/2004
3	Phenylalanine (L-Phenylalanine)FDA Link 03/2012 - 11/2009
2	tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA 01/2019 - 11/2012
2	Substance PIBA 10/2017 - 04/2011
2	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 10/2011
2	Prorenin ReceptorIBA 01/2016 - 10/2014
2	phenylalanylphenylalanineIBA 09/2013 - 10/2005
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2012 - 11/2009
2	hydroxide ionIBA 02/2012 - 11/2009
2	cyclohexylalanineIBA 02/2012 - 01/2007
2	delta Opioid Receptors (delta Opioid Receptor)IBA 11/2009 - 10/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	CarbohydratesIBA 01/2016
1	NociceptinIBA 01/2016
1	PeptidomimeticsIBA 12/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015
1	prostaglandin-inositol cyclic phosphateIBA 11/2015
1	Insulin (Novolin)FDA Link 10/2014
1	ReninIBA 10/2014
1	A 19IBA 10/2014
1	2- tyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA 09/2013
1	2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA 02/2012
1	Opioid Receptors (Opioid Receptor)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 10/2011
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 04/2011
1	LipopolysaccharidesIBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	1,2-dibromo-3-chloropropane (DBCP)IBA 11/2009
1	DipeptidesIBA 11/2009
1	morphiceptinIBA 04/2008
1	Amino Acids FDA Link 01/2007
1	1,3-di(4-imidazolinophenoxyl)propaneIBA 10/2005
1	mu Opioid Receptors (mu Opioid Receptor)IBA 05/2005
1	Naloxone (Narcan)FDA LinkGeneric 03/2005

Therapy/Procedure

2	Therapeutics 10/2014 - 11/2011
1	Drug Therapy (Chemotherapy) 01/2018
1	Ligation 11/2012
1	Analgesia 03/2005